Skip to main content
Equibles
AVR logo

AVR · Anteris Technologies Global Corp.

Track AVR — free

Use AVR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.35 +0.05 (+0.60%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$813.78M
Shares
97.46M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.35 Open$8.41 Day$8.10–8.57 52W close$3.38–10.57 Avg vol 30d746K Short int7.0M · 7.2% float · 9.9d Short vol60% DataDec 2024–Sep 2026 Filing10-Q · Aug 11

Up next

Latest filing: 10-Q
filed Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.24M
Trailing 12 months
Net income (TTM)
−$103.50M
Trailing 12 months
Revenue growth YoY
+63.3%
Year over year
Operating margin
-4,738.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-10.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$249.90M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+169.9%
Year over year · more shares
Price change (1Y)
+67.0%
Trailing year
Short interest
7.2%
Latest settlement · 9.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg +19%
above
Price vs 50-day avg −5%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 69%
mid-range
Momentum
relative strength
Strong
1-month return −6%
trailing
6-month return +49%
trailing
YTD return +67%
this year
Relative strength +31%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $7 — 50d above 200d
Institutional flow Accumulating
+7% holders QoQ · +28 funds added
Insider flow Distributing
Net -$25.2M over 90 days · 100% sells
Short interest Rising
7.15% of float · ▲ +0.6% MoM · 9.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
137 holders — near 1-yr high, broad support
Squeeze score 73
high risk · 0–100
Fundamentals
Weak
Revenue growth −29%
Y/Y
EPS growth +31%
Y/Y
Free cash flow $-79.8M
Quant / Vol
risk profile
Very High
Volatility 70%
annualized · 1-yr
Max drawdown −47%
past year
ATR 5.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+19% Bullish
Price vs 50-day avg
−5% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
69% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $9 › 200d $7 — 50d above 200d
Institutional flow Accumulating
+7% holders QoQ · +28 funds added
Insider flow Distributing
Net -$25.2M over 90 days · 100% sells
Short interest Rising
7.15% of float · ▲ +0.6% MoM · 9.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
137 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $8 · 69% Range high $11
vs 200-day avg +19% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AVR
Anteris Technologies Global Corp.
this stock
$813.78M +67.3% -29.2% — 7.2%
ABT
Abbott Laboratories
 $177.58B -18.6% +5.7% 28.6 1.3%
MDT
Medtronic plc
 $116.35B -5.3% +8.4% 22.4 0.9%
SYK
Stryker Corp
 $105.70B -21.6% +11.2% 28.6 2.0%
BSX
Boston Scientific Corp
 $62.29B -54.9% +12.5% 17.4 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
137
% held
66.9%
Net QoQ
+855.5K sh
Top holder
L1 Capital Pty Ltd
Held Float
View
Held by Funds
Fund positions
101
View
Short & Settlement
Short Interest Rising
Shares short
7.0M
Days to cover
9.9d
Change
+41.9K sh
View
Short Volume
Short vol %
60%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
1.2K
Value
$11.0K
As of
Aug 12, 2026
View
Off-Exchange
Off-exchange %
46.8%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$25.2M
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.9M
Net income (FY)
$-94.1M
EPS diluted
$-2.55
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 8, 2026
This year
16
View
Exempt Offerings
Offering
$11.5M
Filed
Nov 7, 2025
View

Performance

5D 20D 120D MTD YTD
AVR -4.2% -6.5% +49.1% -3.0% +67.3%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -3.1% -4.7% +31.3% -2.7% +55.3%
Key facts CIK 2011514 CUSIP 03675P102 13F (30d) 59 filings 59 filers Visit website Investor relations